Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.38% |
| 2 | Healthcare | 7.46% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 5.11% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
CF Industries
CF
$19.6B
| $109M | 0.05% |
1,574,020
-97,947
| -6% | -$6.83M |
|
|
EDR
327
DELISTED
Endeavor Group Holdings, Inc.
EDR
| $109M | 0.05% |
4,567,872
-2,684,223
| -37% | -$63.2M |
|
328
CALL
RTX Corp
RTX
$283B
| $109M | 0.05% |
1,114,400
+200,600
| +22% | +$19.6M |
|
329
Cognizant
CTSH
$27.9B
| $109M | 0.05% |
1,664,576
+492,759
| +42% | +$30.5M |
|
330
Burlington
BURL
$20.6B
| $109M | 0.05% |
689,407
+139,476
| +25% | +$23.9M |
|
331
KKR & Co
KKR
$97.4B
| $108M | 0.05% |
1,935,976
+1,609,372
| +493% | +$84.3M |
|
332
L3Harris
LHX
$49.7B
| $108M | 0.05% |
551,736
+26,134
| +5% | +$5M |
|
|
LSI
333
DELISTED
Life Storage, Inc.
LSI
| $108M | 0.05% |
812,194
+179,600
| +28% | +$23.9M |
|
334
Align Technology
ALGN
$11.5B
| $108M | 0.05% |
305,315
-21,146
| -6% | -$6.73M |
|
335
Corteva
CTVA
$54.6B
| $108M | 0.05% |
1,877,933
-916,313
| -33% | -$53.5M |
|
336
CALL
Coca-Cola
KO
$392B
| $108M | 0.05% |
1,785,300
-1,614,800
| -47% | -$100M |
|
337
Alcoa
AA
$13.7B
| $107M | 0.05% |
3,161,242
+2,949,850
| +1,395% | +$107M |
|
338
MetLife
MET
$60B
| $107M | 0.05% |
1,886,534
+941,521
| +100% | +$52.2M |
|
339
Bristol-Myers Squibb
BMY
$137B
| $106M | 0.05% |
1,661,979
+9,896
| +0.6% | +$664K |
|
340
OR Royalties Inc
OR
$6.76B
| $106M | 0.05% |
6,888,389
+446,488
| +7% | +$7.23M |
|
341
AMN Healthcare
AMN
$1.33B
| $106M | 0.05% |
968,606
+601,148
| +164% | +$57M |
|
342
Teva Pharmaceuticals
TEVA
$43.5B
| $106M | 0.05% |
14,030,069
+7,835,223
| +126% | +$63.5M |
|
343
DTE Energy
DTE
$28.1B
| $105M | 0.05% |
958,853
-1,359,456
| -59% | -$152M |
|
344
PUT
SPDR Gold Trust
GLD
$152B
| $105M | 0.05% |
591,100
-864,900
| -59% | -$159M |
|
345
CALL
McDonald's
MCD
$192B
| $105M | 0.05% |
352,300
-105,700
| -23% | -$30.7M |
|
346
WEC Energy
WEC
$34.5B
| $105M | 0.05% |
1,190,849
+712,810
| +149% | +$65.9M |
|
347
PUT
AbbVie
ABBV
$468B
| $105M | 0.05% |
779,400
-410,100
| -34% | -$60.1M |
|
348
CALL
Goldman Sachs
GS
$303B
| $105M | 0.05% |
324,500
-96,500
| -23% | -$31.7M |
|
349
HCA Healthcare
HCA
$92.9B
| $104M | 0.05% |
342,614
+310,536
| +968% | +$86.3M |
|
350
Glaukos
GKOS
$10.9B
| $104M | 0.05% |
1,454,405
+156,353
| +12% | +$8.98M |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander deployed $14B of net new capital in Q2 2023, opening 870 new positions and adding to 2,213 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.